Abstract:OBJECTIVE:We conducted a study to identify gender differences in factors associated with the first episode of non-adherence in the 12 months following the first antiretroviral prescription.METHODS:A concurrent prospective study of patients initiating antiretroviral therapy in Brazil was conducted from 2001-2002. The self-reported measurement of adherence was defined as an intake of less than 95% of the prescribed number of doses. Only the first occurrence of non-adherence was considered in this analysis. All a… Show more
“…This low level of non-adherence to ART highlights the success of the national ART program in Kenya, where non-adherence levels are lower than reported in other sub-Saharan African countries, including: Rwanda, where 23% of ART patients were non-adherent based on 30-day recall [14]; Ghana, where 14% of ART patients were non-adherent [15]; rural Zambia where 40% of ART patients were not adherent [16], and a pooled analysis of African adherence studies, where overall non-adherence levels were reported to be 23% [17]. Data from developed countries also suggest higher non-adherence levels, with estimates of 45% in a pooled analysis of adherence studies in North America [17], 37% in Sweden [18], 34% in Brazil [19], and 43% in Spain [20]. Studies that have combined indicators of dose, timing, food and other measures have also generally reported higher non-adherence rates, [21–22].…”
IntroductionUnderstanding the levels and associated factors of non-adherence to antiretroviral therapy (ART) is crucial in designing interventions to improve adherence and health outcomes of ART. We assessed non-adherence to ART among HIV-infected persons reporting ART use in a nationally representative survey in Kenya.MethodsThe Kenya AIDS Indicator Survey 2012 was a population-based, household survey of persons aged 18 months-64 years conducted in 2012–2013. Self-reported information was collected on demographics, sexual behaviour, HIV status, and ART use. Blood was collected for HIV testing, and if HIV infected, CD4 and viral load testing. HIV-positive specimens were tested for the presence of antiretroviral (ARV) drugs using a qualitative ARV assay using liquid chromatography-tandem mass spectrometry. HIV-positive persons who reported receiving ART but did not have the ARV biomarker present were defined as being non-adherent to their ARV medication. We restricted our analysis to HIV-infected persons aged 15–64 years who reported receiving ART and had laboratory-confirmed results from ARV testing. Multivariate logistic regression was used to identify variables associated with non-adherence.ResultsA total of 648 (5.6%; CI 4.9–6.3) tested HIV-positive of whom 559 (86.3%) had sufficient volume of blood to be tested for ARV drugs. Of those, 271 (47.7%; CI 41.8–53.6) self-reported HIV-positive status during the interview and 186 (69.1%; CI 62.2–76.0) of those reported taking ART. The ARV biomarker was absent in 18 of 186 individuals (9.4%; CI 4.9–13.8) who thus were defined as being non-adherent to ART. Non-adherence was associated with being aged 15–29 years (AOR 8.39; CI 2.26–31.22, p = 0.002) compared to aged 30–64 years, rural residence (AOR 5.87; CI 1.39–25.61, p = 0.016) compared with urban residence and taking recreational drugs in the past 30 days (AOR 5.89; CI 1.30–26.70, p = 0.022).ConclusionOverall, less than 10% of Kenyans aged 15–64 years on ART were not adhering to their HIV medication, highlighting the success of the Kenyan national ART program. Our findings, however, point to the need for targeted interventions particularly for young persons, those in rural areas to improve adherence outcomes, as well as delivery of treatment programs that include psychosocial support as a preventative measure to minimize substance abuse and the risk of treatment failure.
“…This low level of non-adherence to ART highlights the success of the national ART program in Kenya, where non-adherence levels are lower than reported in other sub-Saharan African countries, including: Rwanda, where 23% of ART patients were non-adherent based on 30-day recall [14]; Ghana, where 14% of ART patients were non-adherent [15]; rural Zambia where 40% of ART patients were not adherent [16], and a pooled analysis of African adherence studies, where overall non-adherence levels were reported to be 23% [17]. Data from developed countries also suggest higher non-adherence levels, with estimates of 45% in a pooled analysis of adherence studies in North America [17], 37% in Sweden [18], 34% in Brazil [19], and 43% in Spain [20]. Studies that have combined indicators of dose, timing, food and other measures have also generally reported higher non-adherence rates, [21–22].…”
IntroductionUnderstanding the levels and associated factors of non-adherence to antiretroviral therapy (ART) is crucial in designing interventions to improve adherence and health outcomes of ART. We assessed non-adherence to ART among HIV-infected persons reporting ART use in a nationally representative survey in Kenya.MethodsThe Kenya AIDS Indicator Survey 2012 was a population-based, household survey of persons aged 18 months-64 years conducted in 2012–2013. Self-reported information was collected on demographics, sexual behaviour, HIV status, and ART use. Blood was collected for HIV testing, and if HIV infected, CD4 and viral load testing. HIV-positive specimens were tested for the presence of antiretroviral (ARV) drugs using a qualitative ARV assay using liquid chromatography-tandem mass spectrometry. HIV-positive persons who reported receiving ART but did not have the ARV biomarker present were defined as being non-adherent to their ARV medication. We restricted our analysis to HIV-infected persons aged 15–64 years who reported receiving ART and had laboratory-confirmed results from ARV testing. Multivariate logistic regression was used to identify variables associated with non-adherence.ResultsA total of 648 (5.6%; CI 4.9–6.3) tested HIV-positive of whom 559 (86.3%) had sufficient volume of blood to be tested for ARV drugs. Of those, 271 (47.7%; CI 41.8–53.6) self-reported HIV-positive status during the interview and 186 (69.1%; CI 62.2–76.0) of those reported taking ART. The ARV biomarker was absent in 18 of 186 individuals (9.4%; CI 4.9–13.8) who thus were defined as being non-adherent to ART. Non-adherence was associated with being aged 15–29 years (AOR 8.39; CI 2.26–31.22, p = 0.002) compared to aged 30–64 years, rural residence (AOR 5.87; CI 1.39–25.61, p = 0.016) compared with urban residence and taking recreational drugs in the past 30 days (AOR 5.89; CI 1.30–26.70, p = 0.022).ConclusionOverall, less than 10% of Kenyans aged 15–64 years on ART were not adhering to their HIV medication, highlighting the success of the Kenyan national ART program. Our findings, however, point to the need for targeted interventions particularly for young persons, those in rural areas to improve adherence outcomes, as well as delivery of treatment programs that include psychosocial support as a preventative measure to minimize substance abuse and the risk of treatment failure.
“…The psychological changes often associated with HIV and their predictive factors are mood disorders, anxiety, depression, stress related to the health-disease process, history of psychiatric disorder, drug use and suicide in the family. Social support and early detection of those factors and symptoms of psychological distress, quality of life and adherence to treatment where are essential so that they do not adversely affect the treatment adherence and quality of life of people living with HIV/AIDS (PLHA) [16][17][18][19][20][21][22].…”
Background: The origin of temporomandibular dysfunction (TMD)is complex and associates with several factors, including emotional states, such as depression, currently considered one of the main etiological factors of TMD. In this context, people living with the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) may be susceptible to TMD, since the disease may trigger physical and psychological changes identified as risk factors for TMD by other authors.Objective: to measure the prevalence of Temporomandibular Dysfunction and its association with the degree of depression in people living with HIV/AIDS and their sociodemographic characteristics.Method: Cross-sectional, descriptive, exploratory study, developed through the application of Fonseca's instrument for evaluation of TMD and the Beck Depression Inventory (BDI) in people living with HIV/AIDS from the Expert Assistance Service (EAS). For data analysis, one used Fisher's exact test with statistical significance level p<0.05.
Results:The study enrolled 32 subjects, of whom the majority was pardo (65.63%), had incomplete elementary school (43.75%), was single (56.25%), with income lower than or equal to the minimum wage (87.5%) and, in this sample, there was a prevalence of TMD in 68.76%, and of depression in 78.14%
Conclusions:There was a prevalence of Depression and Temporomandibular Dysfunction in the majority of the sample, and a signifi-
“…The Brazil is the country in Latin America with the largest number of reported cases since the beginning of the epidemic, being logged, according to the Ministry of health (MS) from 1982 until June 2014, 656,701 cases of AIDS [2,3]. On the other hand, has advanced in public policies to combat the disease, with the support of international agencies, becoming focus of civil society organizations, philanthropic, religious, among others [1,4].…”
Section: Introductionmentioning
confidence: 99%
“…According to the Joint United Nations programme on HIV/aids (UNAIDS) worldwide there is 35.3 million people living with HIV. It is estimated that 0.8% of adults aged 15-49 years in the world living with the virus and 9,700,000 people are in treatment [2,3].…”
Section: Introductionmentioning
confidence: 99%
“…intentional process, political and technical, configuring itself as an ethical and social responsibility. In this evaluation process, are conspicuous by their user satisfaction in all the peculiarities of local services for adherence to treatment is increasingly effective [2,3].…”
Objective: Develop and validate a measure of satisfaction of outpatient care for people living with acquired immunodeficiency syndrome, as well as assess the satisfaction with the quality of outpatient service provided to these users.Method: This is a methodological study, conducted in a hospital of infect-contagious diseases in Brazil. The sample was composed of 626 people living with AIDS and 56 specialists. As an instrument of data collection using an instrument developed for this study. A factor analysis was tested by calculating the index of Kaiser-Meyer-Olkin (KMO), inspection of the correlation matrix of the items and the test of sphericity of Bartlett.
Results:The main indicators listed form: to availability of anti-retroviral drugs and laboratory tests, physical structure, respect for privacy, relationships, timing, chance to complain, quality of actions received support offered, communication, ease of access, attendance and reception schedules. The measure of service satisfaction demonstrated factor ability indication of the array with a resolution to a single factor (alpha = 0.963) and variance explained of 71.7%. There was a significant difference only to the place of origin of the patient, and those from the State more dissatisfied.
Conclusion:The evaluation of satisfaction proved a strategy planning and evaluation of health services in the pursuit of improving quality of care for patients with a diagnosis of AIDS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.